← Back to all trials
Recruiting
NCT07307781
Study of Patient With Frequent Exacerbations in Moscow
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Sex: All
Ages: 18 Years – 100 Years
Healthy volunteers: No
Enrollment: 300
Sponsor: AstraZeneca
Location: Research Site Moscow
Summary
This Study is multicenter, non-interventional, ambispective registry to evaluate the demographic and clinical characteristics, therapeutic approaches and outcomes in COPD outpatients with frequent exacerbations in Moscow
Eligibility Criteria
Inclusion Criteria:
1. Age ≥18 years at the time of inclusion;
2. Signed and dated written informed consent in accordance with ICH GCP and local law prior to inclusion in the study;
3. Confirmed diagnosis of moderate-to-very severe (GOLD 2-4) COPD established by spirometry demonstrating a post-bronchodilator ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) \
Source: ClinicalTrials.gov (NCT07307781). StuddyBuddy aggregates publicly available trial information.
